Keyword: Ironwood Pharmaceuticals

In a new TV ad, people sit on a toilet waiting. They soon emerge smiling and give a fist pump of victory to the tagline, “Say Yes to Linzess.”

Just a few months after playing a pivotal role in Sanofi’s Bioverativ buy, Alex Denner has set his sights on Ironwood.

Buried in OTC remedies like laxatives, fiber and probiotics? That's the question in Allergan and Ironwood's latest Linzess ads.

What do constipation and gout have in common? Ironwood is leveraging its primary care sales force to hawk meds to treat both.

Growing the gout market has been slow going for Ironwood. But now, the company has a new catalyst.

Winning an award for advertising effectiveness may not be as sexy as winning one for creative, but to pharma brands, it might be more significant.

Every drugmaker wants to find differentiators for their products. And for Ironwood ($IRWD), it was obvious. Is this a constipation drug that improves abdominal symptoms, or is this an abdominal...